CN109641891B - 新化合物和方法 - Google Patents

新化合物和方法 Download PDF

Info

Publication number
CN109641891B
CN109641891B CN201780046788.1A CN201780046788A CN109641891B CN 109641891 B CN109641891 B CN 109641891B CN 201780046788 A CN201780046788 A CN 201780046788A CN 109641891 B CN109641891 B CN 109641891B
Authority
CN
China
Prior art keywords
compound
formula
reaction
solvent
carbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780046788.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN109641891A (zh
Inventor
彼得·莱昂内尔·斯帕戈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Verona Pharmaceutical Co ltd
Original Assignee
Verona Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Ltd filed Critical Verona Pharma Ltd
Publication of CN109641891A publication Critical patent/CN109641891A/zh
Application granted granted Critical
Publication of CN109641891B publication Critical patent/CN109641891B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201780046788.1A 2016-07-28 2017-07-27 新化合物和方法 Active CN109641891B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
GB1613054.4 2016-07-28
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (2)

Publication Number Publication Date
CN109641891A CN109641891A (zh) 2019-04-16
CN109641891B true CN109641891B (zh) 2021-05-04

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780046788.1A Active CN109641891B (zh) 2016-07-28 2017-07-27 新化合物和方法

Country Status (19)

Country Link
US (1) US10710998B2 (cg-RX-API-DMAC10.html)
EP (1) EP3490988B1 (cg-RX-API-DMAC10.html)
JP (1) JP6985367B2 (cg-RX-API-DMAC10.html)
KR (1) KR102396059B1 (cg-RX-API-DMAC10.html)
CN (1) CN109641891B (cg-RX-API-DMAC10.html)
CY (1) CY1122138T1 (cg-RX-API-DMAC10.html)
DK (1) DK3490988T3 (cg-RX-API-DMAC10.html)
ES (1) ES2751948T3 (cg-RX-API-DMAC10.html)
GB (1) GB201613054D0 (cg-RX-API-DMAC10.html)
HR (1) HRP20192109T1 (cg-RX-API-DMAC10.html)
HU (1) HUE046509T2 (cg-RX-API-DMAC10.html)
LT (1) LT3490988T (cg-RX-API-DMAC10.html)
PL (1) PL3490988T3 (cg-RX-API-DMAC10.html)
PT (1) PT3490988T (cg-RX-API-DMAC10.html)
RS (1) RS59566B1 (cg-RX-API-DMAC10.html)
SI (1) SI3490988T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201900582T1 (cg-RX-API-DMAC10.html)
TW (1) TWI739871B (cg-RX-API-DMAC10.html)
WO (1) WO2018020249A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2773142T3 (es) 2014-05-12 2020-07-09 Verona Pharma Plc Nuevo tratamiento
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
SI4090654T1 (sl) * 2020-01-17 2025-11-28 Lupin Ltd. Metode, postopki in intermediati za pripravo kromanskih spojin
JP2024517583A (ja) 2021-04-29 2024-04-23 ▲蘇▼州盛迪▲亞▼生物医▲薬▼有限公司 イソキノリノン系化合物及びその用途
JP2024545189A (ja) 2021-12-14 2024-12-05 シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド 三環式縮合複素環系ｐｄｅ３／４二重阻害剤及びその用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
CN121620356A (zh) * 2023-06-26 2026-03-06 维罗纳制药公司 包含恩塞芬汀的颗粒组合物
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
CN122121878A (zh) 2023-09-06 2026-05-29 维罗纳制药有限公司 用于治疗慢性阻塞性肺病（copd）的恩塞芬汀
WO2025168706A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348453A (zh) * 1999-03-31 2002-05-08 韦尔纳利斯有限公司 嘧啶并[6,1－a] 异喹啉－4－酮衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ZW6284A1 (en) 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
SI2603509T1 (sl) 2010-08-09 2014-10-30 Verona Pharma Plc Kristalinična oblika spojine PIRIMIDIO(6,1-A) IZOKINOLIN-4-ENA
JP6560986B2 (ja) 2013-03-15 2019-08-14 ヴェローナ ファーマ ピーエルシー 複合製剤
ES2773142T3 (es) 2014-05-12 2020-07-09 Verona Pharma Plc Nuevo tratamiento
LT3193835T (lt) 2014-09-15 2018-06-11 Verona Pharma Plc Skysta inhaliuojama vaisto forma, apimanti rpl554
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348453A (zh) * 1999-03-31 2002-05-08 韦尔纳利斯有限公司 嘧啶并[6,1－a] 异喹啉－4－酮衍生物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Trequinsin, a potent new antihypertensive vasodilator in the series of 2-(arylimino)-3-alkyl-9,10-dimethoxy-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-ones;BANSI LAL ET AL,;《JOURNAL OF MEDICINAL CHEMISTRY》;19841231;第27卷(第11期);1470-1480 *

Also Published As

Publication number Publication date
JP6985367B2 (ja) 2021-12-22
EP3490988B1 (en) 2019-08-28
SI3490988T1 (sl) 2019-11-29
LT3490988T (lt) 2019-10-10
TWI739871B (zh) 2021-09-21
GB201613054D0 (en) 2016-09-14
TW201806951A (zh) 2018-03-01
DK3490988T3 (da) 2019-10-28
KR102396059B1 (ko) 2022-05-10
HUE046509T2 (hu) 2020-03-30
HRP20192109T1 (hr) 2020-02-21
WO2018020249A1 (en) 2018-02-01
PT3490988T (pt) 2019-10-28
EP3490988A1 (en) 2019-06-05
CN109641891A (zh) 2019-04-16
ES2751948T3 (es) 2020-04-02
PL3490988T3 (pl) 2020-02-28
SMT201900582T1 (it) 2019-11-13
JP2019527228A (ja) 2019-09-26
KR20190034231A (ko) 2019-04-01
US20190330206A1 (en) 2019-10-31
RS59566B1 (sr) 2019-12-31
US10710998B2 (en) 2020-07-14
CY1122138T1 (el) 2020-11-25

Similar Documents

Publication Publication Date Title
KR102396059B1 (ko) 신규 화합물 및 이의 제조방법
CA2707790C (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
CA3039090C (en) Process for preparing btk inhibitors
EP3753933A1 (en) Succinate salt of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
JP2021500386A (ja) リボシクリブおよびその塩の改善された調製のためのプロセス
CN111315722A (zh) 制备月桂酰阿立哌唑的方法
EP4313987B1 (en) Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof
CN114423755A (zh) 用于合成缬苯那嗪的方法
CN111233866B (zh) 托法替尼或其盐的制备方法
US20230128975A1 (en) Process for the preparation of bromodomain inhibitor
RU2861342C2 (ru) Синтез бис-мезилатной соли 4-амино-n-(1-((3-хлор-2-фторфенил)амино)-6-метилизохинолин-5-ил)тиено[3,2-d]пиримидин-7-карбоксамида и ее промежуточных соединений
HK40002783A (en) New compound and process
HK40002783B (en) New compound and process
CN105849115A (zh) 制药方法和中间体
US20250051351A1 (en) Synthesis of a bis-mesylate salt of 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates thereto
HK40101908A (en) Synthesis of a bis-mesylate salt of 4-amino-n-(1 -((3-chloro-2- fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2- d]pyrimidine-7-carboxamide and intermediates thereto
KR20260049231A (ko) 아비박탐 및 이의 중간체를 제조하기 위한 개선된 방법
CN116406365A (zh) 用于制备1-甲基-6-[6-R2-5-甲基-8-(甲基氨基)-4-[(3aS,6aS)-5-甲基-2,3,3a,4,6,6a-六氢吡咯并[2,3-c]吡咯-1-基]-9H-吡啶并[2,3-b]吲哚-3-基]-4-氧代-1,8-萘啶-3-甲酸盐酸盐的方法
WO2026047284A1 (en) Method for the preparation of lisdexamfetamine
CN118125995A (zh) 一种1-(2-甲氧基苯基)哌嗪盐酸盐的合成方法
CN119859139A (zh) 双盐酸安罗替尼的固体形式及其制备方法
CN120424067A (zh) 并环化合物的制备方法及其中间体
CN114634484A (zh) 改进的奥希替尼或其盐的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: London, England

Patentee after: Verona Pharmaceutical Co.,Ltd.

Country or region after: United Kingdom

Address before: British husband

Patentee before: VERONA PHARMA PLC

Country or region before: United Kingdom